BAG3 controls angiogenesis through regulation of ERK phosphorylation

Oncogene

Volumn 31, Issue 50, 2012, Pages 5153-5161

  Falco, A ^a   Festa, M ^a   Basile, A ^a   Rosati, A ^a   Pascale, M ^a   Florenzano, F ^b   Nori, S L ^a   Nicolin, V ^c   Di Benedetto, M ^d   Vecchione, M L ^d   Arra, C ^e   Barbieri, A ^e   De Laurenzi, V ^a,f   Turco, M C ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF CHIETI   (Italy)

Author keywords

angiogenesis; BAG3; tumour

Indexed keywords

B RAF KINASE; BAG3 PROTEIN; CYCLIN D1; CYCLIN E; DUAL SPECIFICITY PHOSPHATASE 6; HEAT SHOCK PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P15; PROTEIN P21; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; UMBILICAL VEIN ENDOTHELIAL CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 6; G1 PHASE; HSP70 HEAT-SHOCK PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR CHAPERONES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROTEIN BINDING;

EID: 84871220001     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.17     Document Type: Article

References (41)

1. Takayama S, Xie Z, Reed JC. An evolutionarily conserved family of Hsp70/Hsc70 molecular chaperone regulators. J Biol Chem 1999; 274: 781-786.
2. Rosati A, Ammirante M, Gentilella A, Basile A, Festa M, Pascale M et al. Apoptosis inhibition in cancer cells: a novel molecular pathway that involves BAG3 protein. Int J Biochem Cell Biol 2007; 39: 1337-1342.
3. Franceschelli S, Rosati A, Lerose R, De Nicola S, Turco MC, Pascale M. Bag3 gene expression is regulated by heat shock factor 1. J Cell Physiol 2008; 215: 575-577.
4. Homma S, Iwasaki M, Shelton GD, Engvall E, Reed JC, Takayama S. BAG3 deficiency results in fulminant myopathy and early lethality. Am J Pathol 2006; 169: 761-773.
5. Romano MF, Festa M, Pagliuca G, Lerose R, Bisogni R, Chiurazzi F et al. BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis. Cell Death Differ 2003; 10: 383-385.
6. Rosati A, Di Salle E, Luberto L, Quinto I, Scala G, Turco MC et al. Identification of a Btk-BAG3 complex induced by oxidative stress. Leukemia 2009; 23: 823-824.
7. Romano MF, Festa M, Petrella A, Rosati A, Pascale M, Bisogni R et al. BAG3 protein regulates cell survival in childhood acute lymphoblastic leukemia cells. Cancer Biol Ther 2003; 2: 508-510.
8. Valdez BC, Murray D, Ramdas L, de Lima M, Jones R, Kornblau S et al. Altered gene expression in busulfan-resistant human myeloid leukemia. Leuk Res 2008; 32: 1684-1697.
9. Liu P, Xu B, Li J, Lu H. BAG3 gene silencing sensitizes leukemic cells to Bortezomib induced apoptosis. FEBS Lett 2009; 583: 401-406.
10. Bonelli P, Petrella A, Rosati A, Romano MF, Lerose R, Pagliuca MG et al. BAG3 protein regulates stress-induced apoptosis in normal and neoplastic leukocytes. Leukemia 2004; 18: 358-360.
11. Tabuchi Y, Ando H, Takasaki I, Feril Jr LB, Zhao QL, Ogawa R et al. Identification of genes responsive to low intensity pulsed ultrasound in a human leukemia cell line Molt-4. Cancer Lett 2007; 246: 149-156.
12. Cesaro E, Montano G, Rosati A, Crescitelli R, Izzo P, Turco MC et al. WT1 protein is a transcriptional activator of the antiapoptotic bag3 gene. Leukemia 2010; 24: 1204-1206.
13. Liao Q, Ozawa F, Friess H, Zimmermann A, Takayama S, Reed JC et al. The antiapoptotic protein BAG-3 is overexpressed in pancreatic cancer and induced by heat stress in pancreatic cancer cell lines. FEBS Lett 2001; 503: 151-157.
14. Chiappetta G, Ammirante M, Basile A, Rosati A, Festa M, Monaco M et al. The antiapoptotic protein BAG3 is expressed in thyroid carcinomas and modulates apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. J Clin Endocrinol Metab 2007; 92: 1159-1163.
15. Gentilella A, Passiatore G, Deshmane S, Turco MC, Khalili K. Activation of BAG3 by Egr-1 in response to FGF-2 in neuroblastoma cells. Oncogene 2008; 27: 5011-5018.
16. Jacobs AT, Marnett LJ. HSF1-mediated BAG3 expression attenuates apoptosis in 4-hydroxynonenal-treated colon cancer cells via stabilization of anti-apoptotic Bcl-2 proteins. J Biol Chem 2009; 284: 9176-9183.
17. Wang HQ, Liu BQ, Gao YY, Meng X, Guan Y, Zhang HY et al. Inhibition of the JNK signalling pathway enhances proteasome inhibitor-induced apoptosis of kidney cancer cells by suppression of BAG3 expression. Br J Pharmacol 2009; 158: 1405-1412.
18. Festa M, Del Valle L, Franco R, Scognamiglio G, Khalili K, De Laurenzi L et al. BAG3 protein is overexpressed in human glioblastoma and is a potential target for its therapy. Am J Pathol 2011; 178: 2504-2512.
19. Ammirante M, Rosati A, Arra C, Basile A, Falco A, Festa M et al. IKKc protein is a target of BAG3 regulatory activity in human tumor growth. Proc Natl Acad Sci USA 2010; 107: 7497-7502.
20. Jung SE, Kim YK, Youn DY, Lim MH, Ko JH, Ahn YS et al. Down-modulation of Bis sensitizes cell death in C6 glioma cells induced by oxygen-glucose deprivation. Brain Res 2010; 1349: 1-10.
21. Dai C, Whitesell L, Rogers AB, Lindquist S. Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell 2007; 130: 1005-1018.
22. Baud V, Karin M. NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009; 8: 33-40.
23. Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, Kohn EC. CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of poly-ubiquitinated Hsp90 client proteins. J Biol Chem 2003; 278: 28490-28500.
24. Doong H, Price J, Kim YS, Gasbarre C, Probst J, Liotta LA et al. CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Oncogene 2000; 19: 4385-4395.
25. Rosati A, Graziano V, De Laurenzi V, Pascale M, Turco MC. BAG3: a multifaceted protein that regulates major cell pathways. Cell Death Dis 2011; 2: e141.
26. Guedez L, Rivera AM, Salloum R, Miller ML, Diegmueller JJ, Bungay PM et al. Quantitative assessment of angiogenic response by the directed in vivo angiogenesis assay. Am J Pathol 2003; 162: 1431-1439.
27. Basile A, Del Gatto A, Diana D, Di Stasi R, Falco A, Festa M et al. Characterization of a designed vascular endothelial growth factor receptor antagonist helical peptide with antiangiogenic activity in vivo. J Med Chem 2011; 54: 1391-1400.
28. Norrby K. In vivo models of angiogenesis. J Cell Mol Med 2006; 10: 588-612.
29. Bodart JF. Extracellular-regulated kinase-mitogen-activated protein kinase cascade: unsolved issues. J Cell Biochem 2010; 109: 850-857.
30. Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 2010; 277: 2-21.
31. Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition. Oncogene 2007; 26: 3227-3239.
32. Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Hypophosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb. Proc Natl Acad Sci USA 1997; 94: 10699-10704.
33. Cánepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF et al. INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 2007; 59: 419-426.
34. Gil J, Peters G. Regulation of the INK4b-ARF-INK4a tumor suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 2006; 7: 667-677.
35. Wainwright LJ, Lasorella A, Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci USA 2001; 98: 9396-9400.
36. Patterson KI, Brummer T, O'Brien PM, Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem J 2009; 418: 475-489.
37. Jurek A, Amagasaki K, Gembarska A, Heldin CH, Lennartsson J. Negative and positive regulation of MAPK phosphatase 3 controls platelet-derived growth factor-induced ERK activation. J Biol Chem 2009; 284: 4626-4634.
38. Owens DM, Keyse SM. Differential regulation of MAP kinase signalling by dualspecificity protein phosphatases. Oncogene 2007; 26: 3203-3213 Review.
39. Ramos JW. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int J Biochem Cell Bio 2008; 40: 2707-2719.
40. Katz M, Amit I, Yarden Y. Regulation of MAPKs by growth factors and receptor tyrosine kinases. Biochim Biophys Acta 2007; 1773: 1161-1176.
41. Song J, Takeda M, Morimoto R. Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol 2001; 3: 276-282.